Market closedNon-fractional
XBiotech/XBIT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About XBiotech
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
Ticker
XBIT
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
Austin, United States
Employees
92
Website
www.xbiotech.com
XBiotech Metrics
BasicAdvanced
$214M
Market cap
-
P/E ratio
-$1.01
EPS
1.49
Beta
-
Dividend rate
Price and volume
Market cap
$214M
Beta
1.49
Financial strength
Current ratio
12.027
Quick ratio
11.963
Total debt to equity
4.778
Interest coverage (TTM)
-206.09%
Management effectiveness
Return on assets (TTM)
-10.96%
Return on equity (TTM)
-13.78%
Valuation
Price to book
1.04
Price to tangible book (TTM)
1.04
Price to free cash flow (TTM)
-9.834
Growth
Earnings per share change (TTM)
-1.53%
3-year earnings per share growth (CAGR)
28.93%
XBiotech Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$10M
117.39%
Profit margin
0.00%
NaN%
XBiotech Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q1 20
Q2 20
Q3 20
Q4 20
Actual
-
-$0.24
-$0.09
-$0.06
Expected
-
-
-
-
Surprise
-
-
-
-
XBiotech News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for XBiotech stock?
XBiotech (XBIT) has a market cap of $214M as of July 27, 2024.
What is the P/E ratio for XBiotech stock?
The price to earnings (P/E) ratio for XBiotech (XBIT) stock is 0 as of July 27, 2024.
Does XBiotech stock pay dividends?
No, XBiotech (XBIT) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next XBiotech dividend payment date?
XBiotech (XBIT) stock does not pay dividends to its shareholders.
What is the beta indicator for XBiotech?
XBiotech (XBIT) has a beta rating of 1.49. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell XBiotech stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.